KFDA notifies 182 substitutive drugs to KPA.

Published: 2006-05-01 06:55:00

Updated: 2006-05-01 06:55:00

9 products including Alend 70mg tab. were earlier suspended to reimburse by the NHI scheme due to the bio equivalency test fabrication, for which, instead, the KFDA sent an official notification to the Korea Pharmaceutical Association (KPA) about 182 substitutive drugs.

The substitutive drugs notified to the KPA included Kwangdong's Neugatin capsule, Dream Pharma's Dream Pharma Gabapentin 30...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.